Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced (Inoperable) or Metastatic Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Capivasertib|DRUG: Placebo
Sponsor: AstraZeneca